Two more US biotech companies have expressed willingness to supply the Philippines with COVID-19 vaccines, Philippine Ambassador to the US Babes Romualdez said on Friday.

This file photo taken on November 18, 2020 shows a bottle reading “Vaccine Covid-19” next to the Moderna biotech company logo.

Aside from Pfizer, Romualdez said Moderna and Arcturus are “ready to supply” around four to 25 million of their respective COVID-19 vaccines to the Philippines by the third quarter of 2021 should the government “find their proposals acceptable.”

“We are hoping our government will consider the promising candidates of Moderna and Arcturus for inclusion in our country’s pool of anti-COVID vaccines,” Romualdez said.

Arcturus’ COVID candidate ARCT-021 was developed with the Duke-NUS Medical School in Singapore. ARCT-021 uses a messenger RNA (mRNA) technology like the vaccines developed by Moderna and Pfizer.

The vaccine is currently in its Phase I/II trial, according to a report by CNBC.

Moderna, on the other hand, has been recommended for emergency approval in the United States by its panel of experts.

Romualdez said the country’s procurement of COVID-19 vaccines from Pfizer is still “in progress.”

Source: Manila Bulletin (